Geode Capital Management, LLC Pear Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.21 - $1.24 $406 - $2,398	1,934 Added 0.18%	1,050,879 $273,000
Q4 2022 Feb 13, 2023	BUY	$0.99 - $2.91 $13,377 - $39,322	13,513 Added 1.31%	1,048,945 $1.24 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $2.27 $89,460 - $1.56 Million	688,154 Added 198.16%	1,035,432 $2.11 Million
Q2 2022 Aug 12, 2022	BUY	$1.54 - $6.48 $96,581 - $406,393	62,715 Added 22.04%	347,278 $534,000
Q1 2022 May 13, 2022	BUY	$3.67 - $7.63 $831,291 - $1.73 Million	226,510 Added 390.18%	284,563 $1.44 Million
Q4 2021 Feb 11, 2022	BUY	$4.98 - $10.0 $289,103 - $580,530	58,053 New	58,053 $359,000

23M

Ticker PEAR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 138,768,992
Market Cap $1.39M
Description
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.